Hematologic malignancies Clinical Trials
Conditions / Hematologic malignancies
Delta Trials tracks 1 clinical trial for Hematologic malignancies in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 0 trials have reached completion. This research is carried out at 21 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
21
Study Locations
Browse by location (21 total)
- New York, United States 1 trialAll trials in New York, United States
- Melbourne, Australia 1 trialAll trials in Melbourne, Australia
- La Jolla, United States 1 trialAll trials in La Jolla, United States
- Omaha, United States 1 trialAll trials in Omaha, United States
- Ghent, Belgium 1 trialAll trials in Ghent, Belgium
- Duarte, United States 1 trialAll trials in Duarte, United States
- Woolloongabba, Australia 1 trialAll trials in Woolloongabba, Australia
- Houston, United States 1 trialAll trials in Houston, United States
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- Verona, Italy 1 trialAll trials in Verona, Italy
- Edegem, Belgium 1 trialAll trials in Edegem, Belgium
- Nashville, United States 1 trialAll trials in Nashville, United States
- Leuven, Belgium 1 trialAll trials in Leuven, Belgium
- Milan, Italy 1 trialAll trials in Milan, Italy
- Copenhagen, Denmark 1 trialAll trials in Copenhagen, Denmark
- Adelaide, Australia 1 trialAll trials in Adelaide, Australia
- Ann Arbor, United States 1 trialAll trials in Ann Arbor, United States
- Rome, Italy 1 trialAll trials in Rome, Italy
- Aarhus, Denmark 1 trialAll trials in Aarhus, Denmark
- Brussels, Belgium 1 trialAll trials in Brussels, Belgium